Derek Meisner
Patrimonio netto: 452 397 $ in data 31/05/2026
Patrimonio netto: 452 397 $ in data 31/05/2026
Derek M.
Meisner is Secretary & Chief Legal Officer at Acumen Pharmaceuticals, Inc. since 2022.
Mr. Meisner is Vice President-Operations at Greenfire Resources Ltd. starting in 2026.
Former positions include General Counsel at RA Capital Management LP, Partner at K&L Gates LLP, General Counsel at Quantopian, Inc. from 2016 to 2018, Principal at the US Securities & Exchange Commission, General Counsel at Genocea Biosciences, Inc. from 2018 to 2019, and Secretary & Chief Legal Officer at X4 Pharmaceuticals, Inc. from 2019 to 2022.
Education includes undergraduate studies at the University of Michigan and graduate studies at American University Washington College of Law.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 06/03/2026 | 173.999 ( 0,24% ) | 452 397 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Consigliere Generale | 01/08/2022 |
| GREENFIRE RESOURCES LTD. | Direttore operativo | 12/03/2026 |
| Società | Posizione | Fine |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Consigliere Generale | 22/08/2022 |
| GENOCEA BIOSCIENCES, INC. | Consigliere Generale | 01/11/2019 |
Quantopian, Inc.
Quantopian, Inc. Internet Software/ServicesTechnology Services Operates as an online crowdsourced algorithmic trading platform that enables users to develop, test and license trading strategies | Consigliere Generale | 01/01/2018 |
US Securities & Exchange Commission
US Securities & Exchange Commission Investment Banks/BrokersFinance Provides securities and commission services | Corporate Officer/Principal | - |
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Consigliere Generale | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 10 |
|---|---|
Acumen Pharmaceuticals, Inc.
Acumen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops medicines and diagnostics for Alzheimer's disease | Health Technology |
RA Capital Management LP
RA Capital Management LP Investment ManagersFinance RA Capital is a multi-stage investment manager that focuses evidence-based investing in public and private healthcare and life science companies which develops drugs, medical devices, diagnostics, services, and research tools. The firm’s portfolio of private and public companies spans the globe and most therapeutic areas across all stages from discovery through commercialization. | Finance |
Genocea Biosciences, Inc.
Genocea Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that discovers and develops novel cancer immunotherapies | Health Technology |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
US Securities & Exchange Commission
US Securities & Exchange Commission Investment Banks/BrokersFinance Provides securities and commission services | Finance |
K&L Gates LLP
K&L Gates LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
Quantopian, Inc.
Quantopian, Inc. Internet Software/ServicesTechnology Services Operates as an online crowdsourced algorithmic trading platform that enables users to develop, test and license trading strategies | Technology Services |
American University Washington College of Law
American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Greenfire Resources Ltd.
Greenfire Resources Ltd. Integrated OilEnergy Minerals Explores, acquires, develops and produces oil and gas | Energy Minerals |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale